Sufficient trial size to inform clinical practice.
Medical research has evolved conventions for choosing sample size in randomized clinical trials that rest on the theory of hypothesis testing. Bayesian statisticians have argued that trials should be designed to maximize subjective expected utility in settings of clinical interest. This perspective is compelling given a credible prior distribution on treatment response, but there is rarely consensus on what the subjective prior beliefs should be. We use Wald's frequentist statistical decision theory to study design of trials under ambiguity. We show that ε-optimal rules exist when trials have large enough sample size. An ε-optimal rule has expected welfare within ε of the welfare of the best treatment in every state of nature. Equivalently, it has maximum regret no larger than ε We consider trials that draw predetermined numbers of subjects at random within groups stratified by covariates and treatments. We report exact results for the special case of two treatments and binary outcomes. We give simple sufficient conditions on sample sizes that ensure existence of ε-optimal treatment rules when there are multiple treatments and outcomes are bounded. These conditions are obtained by application of Hoeffding large deviations inequalities to evaluate the performance of empirical success rules.
Department of Economics and Institute for Policy Research, Northwestern University, Evanston, IL 60208; cfmanski@northwestern.edu.
Charles F
CF
Manski
Department of Economics, University of Bristol, Bristol BS8 1TU, United Kingdom; Collegio Carlo Alberto, Moncalieri (TO) 10024, Italy.
Aleksey
A
Tetenov
D001499:Bayes Theorem; D035843:Biomedical Research / Q000706:statistics & numerical data*; D006801:Humans; D015233:Models, Statistical; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D018401:Sample Size
clinical trials; medical decision making; near optimality; sample size